<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149060">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01159860</url>
  </required_header>
  <id_info>
    <org_study_id>IRB Protocol No. 33895</org_study_id>
    <nct_id>NCT01159860</nct_id>
  </id_info>
  <brief_title>Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?</brief_title>
  <official_title>Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Seborrheic keratoses (SK's) are very common, but harmless skin lesions that commonly appear
      during adult life. Patients with seborrheic keratoses frequently desire treatment due to
      symptoms of itching and irritation or for cosmetic purposes. Seborrheic keratoses can be
      easily removed and have been treated in a number of different ways. Two of the simplest and
      most successful ways to remove seborrheic keratoses are cryosurgery and curettage.

      The investigators are conducting this study to see which of these two treatments has the
      best result.

      Approximately 24-30 people will take part in this research study at the Hershey Medical
      Center.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">October 2011</completion_date>
  <primary_completion_date type="Anticipated">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Partial or complete resolution of treated lesion.</measure>
    <time_frame>6 weeks</time_frame>
    <description>Follow up evaluation by a blinded physician along with the gathering of patient information via questionnaires will be obtained at the completion of the study.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Seborrheic Keratosis</condition>
  <arm_group>
    <arm_group_label>Cryosurgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One lesion on the patients' trunk or proximal extremities will be treated with cryosurgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Curettage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One lesion on one side of the patients' trunk or proximal extremities will be treated by curettage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cryosurgery</intervention_name>
    <description>freezing of lesion with liquid nitrogen</description>
    <arm_group_label>Cryosurgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Curettage</intervention_name>
    <description>the lesion will be anesthetized and destroyed with a curette.</description>
    <arm_group_label>Curettage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  have at least 1 seborrheic keratosis on each side of his/her trunk or proximal
             extremities.

          -  be able to understand the consent form and evaluation of treatment questionnaire.

        Exclusion Criteria:

          -  Children &lt;18 are excluded from this study based on their inability to independently
             complete the informed consent and research associated questionnaire.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lance D. Wood, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Milton S. Hershey Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brodsky J. Management of benign skin lesions commonly affecting the face: actinic keratosis, seborrheic keratosis, and rosacea. Curr Opin Otolaryngol Head Neck Surg. 2009 Aug;17(4):315-20. doi: 10.1097/MOO.0b013e32832d75e3. Review.</citation>
    <PMID>19465852</PMID>
  </reference>
  <reference>
    <citation>Herron MD, Bowen AR, Krueger GG. Seborrheic keratoses: a study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod. Int J Dermatol. 2004 Apr;43(4):300-2.</citation>
    <PMID>15090020</PMID>
  </reference>
  <verification_date>June 2010</verification_date>
  <lastchanged_date>August 24, 2011</lastchanged_date>
  <firstreceived_date>July 9, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Lance Wood</investigator_full_name>
    <investigator_title>Lance D. Wood, MD, Penn State Milton S. Hershey Medical Center</investigator_title>
  </responsible_party>
  <keyword>seborrheic keratoses</keyword>
  <keyword>cryosurgery</keyword>
  <keyword>curettage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Keratosis</mesh_term>
    <mesh_term>Keratosis, Actinic</mesh_term>
    <mesh_term>Keratosis, Seborrheic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
